use
recombin
sever
acut
respiratori
syndrom
coronaviru
sarscov
nucleocapsid
proteinbas
enzymelink
immunosorb
assay
elisa
serum
specimen
serial
collect
day
day
symptom
onset
patient
pneumonia
due
sarscov
analyz
longitudin
profil
immunoglobulin
g
igg
igm
iga
antibodi
sarscov
nucleocapsid
protein
patient
pneumonia
due
sarscov
igg
median
optic
densiti
nm
od
turn
posit
day
biphas
respons
observ
day
patient
still
posit
antinucleocapsid
protein
igg
antibodi
igm
median
od
turn
posit
day
peak
day
fell
baselin
level
day
day
patient
still
posit
antinucleocapsid
protein
igm
antibodi
iga
median
od
turn
posit
day
peak
day
fell
baselin
level
day
day
patient
still
posit
antinucleocapsid
protein
iga
antibodi
time
seroconvers
detect
recombin
sarscov
nucleocapsid
proteinbas
elisa
detect
indirect
immunofluoresc
assay
similar
median
time
seroconvers
igg
igm
iga
detect
indirect
immunofluoresc
assay
day
day
elisa
day
day
elisa
day
day
elisa
respect
diseas
onset
one
four
one
six
patient
die
produc
igg
igm
iga
antibodi
nucleocapsid
protein
sarscov
respect
although
antibodi
detect
six
patient
indirect
immunofluoresc
assay
studi
perform
see
whether
sarscov
nucleocapsid
protein
antibodi
posit
prognost
signific
sever
acut
respiratori
syndrom
sar
affect
countri
five
contin
case
death
novel
viru
sar
coronaviru
sarscov
confirm
etiolog
agent
genom
complet
sequenc
recent
sarscovlik
virus
isol
himalayan
palm
civet
found
live
anim
market
guangdong
provinc
china
find
impli
anim
could
reservoir
ancestor
sarscov
detect
antibodi
sarscov
moment
wide
use
method
antibodi
detect
acuteand
convalescentphas
sera
indirect
immunofluoresc
assay
enzymelink
immunosorb
assay
elisa
cell
cultur
extract
howev
antibodi
detect
indirect
immunofluoresc
assay
elisa
cell
cultur
extract
may
less
reproduc
difficult
standard
laborintens
elisabas
antibodi
detect
test
recombin
antigen
furthermor
product
infect
cell
line
use
coat
elisa
plate
slide
indirect
immunofluoresc
requir
cultiv
sarscov
biosafeti
level
laboratori
facil
requir
facil
avail
clinic
microbiolog
laboratori
elisabas
antibodi
detect
test
recombin
antigen
well
known
offer
higher
reproduc
easier
standard
less
laborintens
antibodi
detect
indirect
immunofluoresc
assay
elisa
cell
cultur
extract
requir
cultiv
sarscov
recent
investig
report
use
recombin
sarscov
nucleocapsid
protein
elisabas
antibodi
test
serodiagnosi
sarscov
pneumonia
studi
seropreval
nonpneumon
sarscov
infect
studi
describ
articl
use
serial
collect
serum
specimen
patient
sarscov
pneumonia
analyz
longitudin
profil
immunoglobulin
g
igg
igm
iga
antibodi
sarscov
nucleocapsid
protein
patient
pneumonia
due
sarscov
time
seroconvers
detect
recombin
sarscov
nucleocapsid
proteinbas
elisa
detect
indirect
immunofluoresc
assay
also
compar
elisa
detect
igg
igm
iga
antibodi
nucleocapsid
protein
sarscov
method
clone
purif
recombin
nucleocapsid
protein
optim
elisa
detect
igg
igm
iga
sarscov
report
previous
elisa
perform
describ
previous
briefli
well
immunopl
nunc
roskild
denmark
coat
purifi
tag
recombin
nucleocapsid
protein
ng
igg
detect
ng
igm
detect
ng
iga
detect
h
block
phosphatebuff
salin
pb
bovin
serum
albumin
dilut
human
sera
igg
detect
igm
detect
iga
detect
ad
well
tag
recombin
nucleocapsid
proteinco
plate
total
volum
l
plate
incub
h
plate
wash
wash
buffer
five
time
l
dilut
horseradish
peroxidaseconjug
goat
antihuman
igg
mous
antihuman
igm
mous
antihuman
iga
antibodi
zyme
laboratori
inc
south
san
francisco
calif
ad
well
plate
incub
h
plate
wash
wash
buffer
five
time
l
dilut
zyme
laboratori
inc
ad
well
plate
incub
room
temperatur
min
one
hundr
microlit
h
ad
absorb
nm
well
measur
sampl
test
duplic
mean
absorb
serum
sampl
calcul
cutoff
valu
optic
densiti
nm
od
igg
igm
iga
detect
respect
longitudin
profil
igg
igm
iga
antibodi
sarscov
nucleocapsid
protein
patient
pneumonia
due
sarscov
serial
serum
sampl
obtain
day
day
symptom
onset
collect
patient
pneumonia
due
sarscov
posit
antibodi
sarscov
detect
indirect
immunofluoresc
assay
serum
sampl
subject
igg
igm
iga
detect
recombin
nucleocapsid
protein
elisa
igg
igm
iga
detect
median
od
valu
serum
specimen
patient
calcul
time
point
comparison
time
seroconvers
detect
recombin
nucleocapsid
protein
elisa
indirect
immunofluoresc
assay
igg
igm
iga
detect
serum
sampl
patient
mention
collect
first
day
onset
ill
subject
igg
igm
iga
detect
indirect
immunofluoresc
assay
describ
time
seroconvers
detect
two
antibodi
test
compar
day
seroconvers
defin
day
od
serum
sampl
reach
valu
cutoff
elisa
day
serum
sampl
dilut
gave
posit
signal
indirect
immunofluoresc
assay
indirect
immunofluoresc
assay
indirect
immunofluoresc
assay
perform
describ
previous
briefli
microscop
slide
coat
sarscovinfect
fetal
rhesu
kidney
cell
fix
aceton
proport
infect
cell
adjust
judg
posit
control
serum
sampl
obtain
patient
pneumonia
due
sarscov
ten
microlit
serum
sampl
dilut
ad
slide
slide
incub
min
slide
wash
pb
three
time
l
fluorescein
isothiocyanateconjug
goat
antihuman
igg
igm
iga
antibodi
inova
diagnost
inc
san
diego
calif
ad
slide
slide
incub
min
slide
wash
pb
three
time
examin
uv
light
illumin
immunofluoresc
microscop
serum
sampl
posit
screen
dilut
retest
use
twofold
serial
dilut
longitudin
profil
igg
igm
iga
antibodi
sarscov
nucleocapsid
protein
patient
pneumonia
due
sarscov
six
patient
pneumonia
due
sarscov
die
day
day
respect
onset
ill
addit
remain
patient
surviv
refus
venipunctur
day
median
od
result
avail
serum
specimen
patient
time
point
calcul
plot
number
day
time
onset
symptom
fig
igg
median
od
rose
baselin
level
day
initi
surg
igg
antibodi
level
drop
transient
day
rose
day
patient
serum
sampl
avail
comparison
time
seroconvers
detect
recombin
nucleocapsid
protein
elisa
indirect
immunofluoresc
assay
igg
igm
iga
detect
time
seroconvers
patient
serial
serum
sampl
collect
confirm
pneumonia
due
sarscov
indirect
immunofluoresc
assay
shown
tabl
igg
detect
median
time
seroconvers
detect
indirect
immunofluoresc
assay
day
rang
day
diseas
onset
wherea
detect
recombin
nucleocapsid
protein
elisa
day
rang
day
diseas
onset
patient
igg
detect
elisa
earlier
indirect
immunofluoresc
assay
wherea
anoth
patient
igg
detect
indirect
immunofluoresc
assay
earlier
elisa
igm
detect
median
time
seroconvers
detect
indirect
immunofluoresc
assay
day
rang
day
diseas
onset
wherea
detect
recombin
nucleocapsid
protein
elisa
day
rang
day
diseas
onset
patient
igm
detect
elisa
earlier
indirect
immunofluoresc
assay
wherea
anoth
patient
igm
detect
indirect
immunofluoresc
assay
earlier
elisa
iga
detect
median
time
seroconvers
detect
indirect
immunofluoresc
assay
day
rang
day
diseas
onset
wherea
detect
recombin
nucleocapsid
protein
elisa
day
rang
day
diseas
onset
patient
iga
detect
elisa
earlier
indirect
immunofluoresc
assay
wherea
anoth
patient
iga
detect
indirect
immunofluoresc
assay
earlier
elisa
present
studi
first
literatur
describ
longitudin
igg
igm
iga
antibodi
profil
patient
pneumonia
due
sarscov
serum
sampl
serial
collect
day
onset
ill
previou
studi
describ
profil
igg
igm
antibodi
sarscov
patient
pneumonia
due
sarscov
elisa
type
antigen
use
mention
igg
igm
antibodi
level
increas
detect
level
second
week
ill
present
studi
level
three
antibodi
igg
igm
iga
increas
detect
level
third
week
ill
specul
differ
could
due
use
corticosteroid
patient
patient
pneumonia
due
sarscov
local
given
corticosteroid
first
day
ill
fact
patient
receiv
cumul
methylprednisolon
dose
g
throughout
treatment
period
high
dose
corticost
roid
could
suppress
effect
patient
antibodi
respons
studi
igm
antibodi
becam
detect
later
igg
antibodi
may
due
earlier
develop
igg
antibodi
igm
antibodi
differenti
sensit
classspecif
elisa
contrast
phenomena
describ
pathogen
igm
antibodi
often
appear
day
earlier
igg
antibodi
previou
studi
mean
igm
antibodi
titer
patient
drop
detect
level
day
hand
median
igm
antibodi
level
patient
still
posit
day
fact
patient
serum
sampl
avail
still
detect
igm
iga
antibodi
day
biphas
igg
respons
patient
could
due
use
corticosteroid
previou
studi
mean
igg
antibodi
level
patient
rose
steadili
maximum
day
onset
ill
hand
median
igg
antibodi
level
patient
drop
slightli
day
onset
ill
fig
slight
drop
igg
antibodi
level
follow
increas
median
igg
antibodi
level
peak
day
fact
phenomenon
biphas
igg
antibodi
respons
seen
patient
patient
igg
level
plateau
transient
day
rise
peak
level
similar
delay
appear
antibodi
specul
also
due
use
corticosteroid
describ
patient
receiv
highdos
corticosteroid
first
day
ill
day
withdraw
corticosteroid
treatment
patient
may
led
secondari
rise
igg
level
give
rise
appar
biphas
igg
antibodi
respons
seen
patient
present
recombin
nucleocapsid
proteinbas
igg
elisa
sensit
similar
indirect
immunofluoresc
assay
serodiagnosi
pneumonia
due
sarscov
previou
studi
shown
serum
sampl
test
posit
indirect
immunofluoresc
assay
igg
detect
test
neg
recombin
nucleocapsid
protein
igg
elisa
howev
five
patient
pneumonia
due
sarscov
seroneg
indirect
immunofluoresc
assay
igg
detect
revers
transcriptionpcr
posit
sarscov
two
igg
antibodi
nucleocapsid
protein
sarscov
detect
recombin
nucleocapsid
protein
igg
elisa
unpublish
data
present
studi
shown
tabl
patient
igg
igm
iga
antibodi
respect
detect
elisa
earlier
indirect
immunofluoresc
assay
hand
anoth
patient
respect
antibodi
detect
indirect
immunofluoresc
assay
earlier
elisa
find
show
present
recombin
nucleocapsid
proteinbas
elisa
sensit
similar
indirect
immunofluoresc
assay
serodiagnosi
pneumonia
due
sarscov
elisa
much
less
laborintens
interpret
result
object
elisa
requir
cultiv
sarscov
present
data
confirm
elisa
could
altern
indirect
immunofluoresc
assay
screen
test
antibodi
sarscov
clinic
microbiolog
laboratori
interestingli
one
four
one
six
patient
die
produc
detect
igg
igm
iga
antibodi
nucleocapsid
protein
sarscov
respect
even
though
antibodi
detect
indirect
immunofluoresc
assay
studi
perform
see
whether
sarscov
nucleocapsid
protein
antibodi
posit
prognost
signific
